Osimertinib (80 mg) Information

This page describes Osimertinib, a targeted treatment for non-small cell lung cancer (NSCLC) with EGFR mutations. It provides general information about this cancer treatment.

  • Viesearch
    Moderated and indexed this listing ·
  • theoncologymeds's profile picture
    Submitted this listing ·

Related Featured

Add yours

Editorial Actions

Feature Edit